Skip to main content

Osteoarthritis Pain Management

Acetaminophen is recommended by the American Geriatrics Society as a first-line therapy for persistent pain, particularly musculoskeletal pain1

NSAIDs may not be suitable for certain OA patients, who often have a higher incidence of comorbidities.1

Osteoarthritis (OA) affects 30 million older adults.* Up to 54% of these patients could have a comorbidity.2,3

TYLENOL®: Proven analgesic efficacy in osteoarthritis−even when inflammation is present4  

At both 1000 mg and 650 mg, the safety and efficacy of TYLENOL® has been well supported by clinical studies and decades of actual use.5-7

Use OA education as exercise motivation

Share this video with patients to promote the benefits of exercise and encourage them to keep moving.

Motivate patients to stay active

People who exercise can reduce their risk of osteoarthritis-related disability by 43%.8

In fact, there is a 50% risk reduction in developing knee OA with weight loss of as little as 11 pounds in overweight women.9

OA can progress over time

It can cause muscle weakening, bone spurs, loss of cartilage, and joint space narrowing.9,10

keep moving Tylenol

The Keep Moving® Program

Designed by the makers of TYLENOL®, this special patient program helps reduce OA-induced pain by providing:

  • Targeted exercises for knees and hips
  • Creative weight loss tips
  • Joint-protection tips

Motivate patients to stay active

Give patients important reasons to move.

TYLENOL® 8 HR Arthritis Pain

Recommend TYLENOL® 8 HR Arthritis Pain

Give patients extended relief from OA.

*OA occurs most often in patients 40 and over.11

†Percentage of consumers age 45+ who have high blood pressure, kidney disease, or are taking low-dose aspirin for heart health and thus may not be appropriate to use NSAIDs.

REFERENCES: 1. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331-1346. 2. Centers for Disease Control and Prevention. Osteoarthritis fact sheet. Updated February 2, 2017. Accessed March 23, 2017. 3. Data on file. McNeil Consumer Healthcare. 2017. 4. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol. 1992;19(12):1950-1954. 5. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325(2):87-91. 6. Dalton JD, Schweinle JE. Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Ann Emerg Med. 2006;48(5):615-623. 7. Qi DS, May LG, Zimmerman B, et al. A randomized, double-blind, placebo-controlled study of acetaminophen 1000 mg versus acetaminophen 650 mg for the treatment of postsurgical dental pain. Clin Ther. 2012;34(12):2247-2258. 8. Penninx BWJH, Messier SP, Rejeski WJ, et al. Physical exercise and the prevention of disability in activities of daily living in older persons with osteoarthritis. Arch Intern Med. 2001;161(19):2309-2316. 9. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41:1343-1355. 10. Wise C. Osteoarthritis. In: Singh AK, ed. Scientific American Medicine. Philadelphia, PA. Decker Intellectual Properties Inc.; 2010:1-12. 11. American College of Rheumatology. Osteoarthritis. Accessed April 17, 2017.